Novo Nordisk A/S Class B · OMXCOP:NOVO_B

Novo Nordisk A/S Class B — Fact Sheet (April 2022)

2 slides from Novo Nordisk A/S Class B's fact sheet, April 2022

  1. Slide 1: The Digital Metabolic Liver Disease Accelerator

    Novo Nordisk® The Digital Metabolic Liver Disease Accelerator The digital Metabolic Liver Disease Accelerator will support 1-2 digital solutions with up to 100.000 USD to pilot their solutions with Novo Nordisk. We believe there is so much to be explored in this space and are therefore open to worki

  2. Slide 2: Why participate? The journey

    2 Novo Nordisk® Why participate? The journey The Digital Metabolic Liver Disease Accelerator Up to 100.000 USD startup funding to test your solution 01 and implement a pilot together with Novo Nordisk The Metabolic Liver Disease Accelerator launch The challenge is open for startups and scaleups to N

Novo Nordisk — Fact Sheet (April 2022) on 6ix